Professor Arshad Majid
School of Medicine and Population Health
Professor of Cerebrovascular Neurology
Consultant Neurologist, Royal Hallamshire Hospital
Chief Investigator, TRICEPS Trial (NIHR EME · Association of British Neurologists · Stroke Association)
Co Chief Investigator, RICFAST Trial (Stroke Association)
arshad.majid@sheffield.ac.uk
+44 114 222 2290
+44 114 222 2290
+44 114 226 8763
(Clinical Secretary: Judy O´Dea)
Sheffield Institute for Translational Neuroscience (SITraN)
Full contact details
Professor Arshad Majid
School of Medicine and Population Health
Sheffield Institute for Translational Neuroscience (SITraN)
385a Glossop Road
Sheffield
S10 2HQ
School of Medicine and Population Health
Sheffield Institute for Translational Neuroscience (SITraN)
385a Glossop Road
Sheffield
S10 2HQ
- Profile
-
My professional mission is to translate cutting‑edge neuroscience into effective therapies for patients with cerebrovascular and other neurological diseases. Following medical graduation from the University of Glasgow, specialist training in Neurology at the University of Pennsylvania, and fellowship training at Washington University in St Louis and the Medical College of Wisconsin, I have pursued a career that bridges bench science and bedside care.
I am honoured to hold the title of NIHR Senior Investigator and to lead major UK multicentre trials:
- TRICEPS (TRanscutaneous Vagus Nerve Stimulation to enhance limb rECovery PoSt‑Stroke) – evaluating whether pairing task‑specific upper‑limb rehabilitation with movement‑activated transcutaneous vagus nerve stimulation improves arm function after stroke.
- RICFAST (Remote Ischaemic Conditioning For fATigue after STroke) – investigating whether repeated brief episodes of limb ischaemia and reperfusion can reduce debilitating post‑stroke fatigue.
Previously I founded the Division of Cerebrovascular Diseases at Michigan State University and the William & Claire Dart Stroke Center at Sparrow Health System before joining the University of Sheffield and Royal Hallamshire Hospital in 2013.
I serve as Director of the Comprehensive Cerebrovascular Research Unit (CCRU). My research has been funded by the NIH, American Heart Association, MRC, NIHR and industry.
- Research interests
-
Key research areas:
- Neuroprotection and Neuroregeneration
- Electroceuticals
- Stroke Clinical Trials,
- Animal and Cellular Models of Stroke and Neuroinflammation
- Novel Drug Delivery (nanotechnology and exosomes)
- Remote Conditioning, Vagus Nerve Stimulation.
- Gene editing, gene blocking & gene replacement for hereditary cerebral small‑vessel diseases — including vascular dementia, COL4A1/COL4A2 mutation‑related angiopathy and CADASIL
Trial / Project Role Focus TRICEPS Chief Investigator Movement-activated tVNS paired with upper-limb rehab to improve arm recovery post-stroke RICFAST Co-Chief Investigator RIC as a home-based intervention for alleviating post-stroke fatigue Gene-block & replacement therapy Principal Investigator CRISPR/Cas-based editing and AAV-mediated replacement for COL4A1/2 disease, CADASIL & vascular dementia Stroke vaccine development Lead Immunomodulatory vaccine to mitigate secondary neuroinflammation after stroke Donations
Help Us Beat Rare Genetic Stroke Disorders
Vascular dementia, CADASIL, and COL4A1/2-related diseases are often inherited, progressive, and devastating. These disorders can cause strokes, cognitive decline, and long-term disability in both children and adults.
No disease-modifying treatments currently exist. Our lab is developing world-first gene-block and gene-replacement therapies that offer real hope to affected families. Traditional research funding often overlooks rare conditions, making philanthropic support absolutely vital to accelerate these breakthroughs.
How You Can Help
- Fund a PhD student or postdoc working on CADASIL or COL4A1 therapy
- Support development of gene therapy vectors for testing in preclinical models
- Sponsor patient registries and biobank infrastructure
- Partner with us to launch early-phase clinical trials
If you or your organisation would like to make a contribution or explore partnership opportunities, please email me directly at arshad.majid@sheffield.ac.uk.
Every contribution, large or small, drives innovation and hope for people affected by genetic stroke disorders.
- Publications
-
Edited books
- Electroceuticals: Advances in Electrostimulation Therapies. Cham: Springer.
Journal articles
- Effects of carnosine supplementation on cognitive outcomes in prediabetes and well-controlled type 2 diabetes: a randomised placebo-controlled clinical trial. Pharmaceuticals, 18(5). View this article in WRRO
- Reprogramming Human Macrophages in Symptomatic Carotid Stenosis: Stabilisation of Atherosclerotic Carotid Plaques. Atherosclerosis, 119180-119180.
- TRanscutaneous lImb reCovEry Post-Stroke (TRICEPS): study protocol for a randomised, controlled, multiarm, multistage adaptive design trial. BMJ Open, 15(3), e092520-e092520.
- Stroke in Bangladesh: A narrative review of epidemiology, risk factors and acute stroke services. Journal of Cardiovascular Development and Disease, 12(2). View this article in WRRO
- Vagus nerve stimulation in intracerebral hemorrhage: the need for further research. Neural Regeneration Research, 20(11), 3213-3214.
- Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: Go broad or go narrow?. Neuropharmacology, 262, 110192-110192.
- Remote ischaemic conditioning for neurological disorders—a systematic review and narrative synthesis. Systematic Reviews, 13(1). View this article in WRRO
- Treatment of cerebral venous thrombosis: a review. Current Medical Research and Opinion, 40(12), 2223-2236. View this article in WRRO
- The protective role of carnosine against type 2 diabetes‐induced cognitive impairment. Food Science & Nutrition, 12(6), 3819-3833. View this article in WRRO
- Gene expression studies in Down syndrome: what do they tell us about disease phenotypes?. International Journal of Molecular Sciences, 25(5). View this article in WRRO
- Histidine-containing dipeptide supplementation improves delayed recall: a systematic review and meta-analysis. Nutrition Reviews, 82(10), 1372-1385.
- Carnosine supplementation improves delayed recall: a systematic review and meta‐analysis. Alzheimer's & Dementia, 19(S21).
- Vagus Nerve Stimulation in Ischemic Stroke. Current Neurology and Neuroscience Reports, 23(12), 947-962.
- Remote ischaemic conditioning for fatigue after stroke (RICFAST): a pilot randomised controlled trial. Journal of Stroke and Cerebrovascular Diseases, 32(12). View this article in WRRO
- tVNS in stroke: a narrative review on the current state and the future. Stroke, 54(10), 2676-2687. View this article in WRRO
- Thrombolysis outcomes in acute ischaemic stroke patients with pre-existing cognitive impairment. Life, 13(4). View this article in WRRO
- Vagus nerve stimulation paired with rehabilitation for upper limb motor impairment and function after chronic ischemic stroke: subgroup analysis of the randomized, blinded, pivotal, VNS-REHAB device trial. Neurorehabilitation and Neural Repair.
- Reply: Antiplatelet Use in Ischemic Stroke. Annals of Pharmacotherapy, 56(12), 1386-1387.
- Neuroprotective efficacy of N-t-butylhydroxylamine (NtBHA) in transient focal ischemia in rats. Toxicological Research, 38(4), 479-486.
- Abstract 1: Vagus Nerve Stimulation Paired With Rehabilitation For Upper Limb Motor Function After Ischaemic Stroke: Sub-group Analysis Of The Randomised, Blinded, Pivotal, Vns-Rehab Device Trial.. Stroke, 53(Suppl_1).
- Antiplatelet use in ischemic stroke. Annals of Pharmacotherapy. View this article in WRRO
- The neurology of space flight; How does space flight effect the human nervous system?. Life Sciences in Space Research.
- Transcutaneous vagus nerve stimulation (tVNS) in stroke: the evidence, challenges and future directions. Autonomic Neuroscience, 237, 102909-102909.
- Neuroprotective Potential of Carnosine in Cerebrovascular Diseases. International Journal of Peptide Research and Therapeutics, 28(1).
- Carnosine protects against cerebral ischemic injury by inhibiting matrix-metalloproteinases. International Journal of Molecular Sciences, 22(14).
- Effect of exercise interventions on health-related quality of life after stroke and transient ischemic attack: a systematic review and meta-analysis. Stroke, 52(7), 2445-2455. View this article in WRRO
- Remote ischaemic conditioning for stroke: unanswered questions and future directions. Stroke and Vascular Neurology, 6(2). View this article in WRRO
- Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. The Lancet, 397(10284), 1545-1553.
- International consensus based review and recommendations for minimum reporting standards in research on transcutaneous vagus nerve stimulation (version 2020). Frontiers in Human Neuroscience, 14.
- A commonly used biocide 2-N-octyl-4-isothiazolin-3-one induces blood–brain barrier dysfunction via cellular thiol modification and mitochondrial damage. International Journal of Molecular Sciences, 22(5).
- Neural progenitor cell-derived extracellular vesicles enhance blood-brain barrier integrity by NF-κB (nuclear factor-κB)-dependent regulation of ABCB1 (ATP-binding cassette transporter B1) in stroke mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(3), 1127-1145.
- LRP-1 functionalized polymersomes enhance the efficacy of carnosine in experimental stroke. Scientific Reports, 10(1). View this article in WRRO
- Adipose‐derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR‐25. Journal of Extracellular Vesicles, 10(1).
- Exercise referral to promote cardiovascular health in stroke and TIA patients : a pilot feasibility study. BMJ Open Sport & Exercise Medicine, 6(1).
- Comparative cerebroprotective potential of d- and l-carnosine following ischemic stroke in mice. International Journal of Molecular Sciences, 21(9). View this article in WRRO
- Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2). Journal of Neurology, Neurosurgery & Psychiatry, 91(4), 396-401. View this article in WRRO
- Autophagy-mediated occludin degradation contributes to blood–brain barrier disruption during ischemia in bEnd.3 brain endothelial cells and rat ischemic stroke models. Fluids and Barriers of the CNS, 17(1).
- Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study. Efficacy and Mechanism Evaluation, 7(1). View this article in WRRO
- Neuroprotective effects of carnosine-loaded elastic liposomes in cerebral ischemia rat model. Journal of Pharmaceutical Investigation, 50(4), 373-381.
- Transcutaneous auricular vagus nerve stimulation with upper limb repetitive task practice may improve sensory recovery in chronic stroke. Journal of Stroke and Cerebrovascular Diseases, 28(12). View this article in WRRO
- Cerebral Venous Thrombosis at High Altitude: Analysis of 28 Cases. Cerebrovascular Diseases, 48(3-6), 184-192.
- Improving the safety of atrial fibrillation monitoring systems through human verification. Safety Science, 118, 881-886.
- The potential of carnosine in brain-related disorders : a comprehensive review of current evidence. Nutrients, 11(6).
- BS22 Double positive (CD86+ MRC1+) inflammatory macrophages in the pathogenesis of carotid atherosclerosis. Basic Science.
- Inhibition of matirx‐metalloproteinases mediates carnosine‐neuroprotection during ischemia. The FASEB Journal, 33(S1).
- Animal models of multiple sclerosis: From rodents to zebrafish.. Multiple Sclerosis Journal, 25(3), 306-324. View this article in WRRO
- Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. The Lancet, 393(10168), 265-274.
- Hypoxia mimetic agents for ischemic stroke. Frontiers in Cell and Developmental Biology, 6. View this article in WRRO
- Aerobic exercise interventions reduce blood pressure in patients after stroke or transient ischaemic attack: a systematic review and meta-analysis. British Journal of Sports Medicine, 53(24), 1515-1525.
- Very Delayed Remote Ischemic Post-conditioning Induces Sustained Neurological Recovery by Mechanisms Involving Enhanced Angioneurogenesis and Peripheral Immunosuppression Reversal. Frontiers in Cellular Neuroscience, 12. View this article in WRRO
- Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review. Brain Stimulation, 11(6), 1225-1238.
- Transcutaneous Auricular Vagus Nerve Stimulation with Concurrent Upper Limb Repetitive Task Practice for Poststroke Motor Recovery: A Pilot Study. Journal of Stroke & Cerebrovascular Diseases, 27(7), 1998-2005. View this article in WRRO
- Role of Autophagy in Endothelial Damage and Blood–Brain Barrier Disruption in Ischemic Stroke. Stroke, 49(6), 1571-1579.
- Methylglyoxal induced advanced glycation end products (AGE)/receptor for AGE (RAGE)-mediated angiogenic impairment in bone marrow-derived endothelial progenitor cells. Journal of Toxicology and Environmental Health, Part A, 81(9), 266-277.
- Central and peripheral processes in headache. Current Opinion in Supportive and Palliative Care, 12(2), 142-147.
- The economic cost of stroke-associated pneumonia in a UK setting. Topics in Stroke Rehabilitation, 25(3), 214-223.
- Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. International Journal of Pharmaceutics, 525(1), 92-100. View this article in WRRO
- Ischemic Post-Conditioning Induces Post-Stroke Neuroprotection via Hsp70-Mediated Proteasome Inhibition and Facilitates Neural Progenitor Cell Transplantation.. Mol Neurobiol. View this article in WRRO
- Systematic review and stratified meta-analysis of the efficacy of carnosine
in animal models of ischemic stroke. Journal of Cerebral Blood Flow and Metabolism, 36(10), 1686-1694. View this article in WRRO
- Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery.. Eur J Pharm Biopharm, 108, 187-195. View this article in WRRO
- Selective inhibition of JAK2/STAT1 signaling and iNOS expression mediates the anti-inflammatory effects of coniferyl aldehyde. Chemico-Biological Interactions, 256, 102-110. View this article in WRRO
- Abstract WP341: Difference in Acute Ischemic Post Thrombolytic Stroke Outcomes in Pre Comprehensive and Post Comprehensive Status: Single Center Experience. Stroke, 47(suppl_1).
- Cerebral Ischemic Preconditioning: the Road So Far…. Molecular Neurobiology, 53(4), 2579-2593.
- Contemporary Trends In The Ischemic Stroke “Weekend Effect” On Iv Thrombolytic Use, In-hospital Mortality, Discharge Disposition, Hospital Charges, And Length Of Stay (P6.242). Neurology, 84(14_supplement).
- The role of relatives in help-seeking for patients with stroke/TIA: Results from Stroke and TIA Awareness and Response to Symptoms (STARS) study. INTERNATIONAL JOURNAL OF STROKE, 10, 121-121.
- Ethnic minority recruitment into stroke research trials at a university teaching hospital in the UK.. CEREBROVASCULAR DISEASES, 39, 287-287.
- Post stroke cognitive and mood screening: The Sheffield experience. INTERNATIONAL JOURNAL OF STROKE, 9, 42-42.
- The Influence of Bolus to Infusion Delays on Plasma Tissue Plasminogen Activator Levels. International Journal of Stroke, 9(7), 939-942.
- Neuroprotective Effect of Asiatic Acid in Rat Model of Focal Embolic Stroke. Biological and Pharmaceutical Bulletin, 37(8), 1397-1401.
- Modulation of Mitochondrial Function and Autophagy Mediates Carnosine Neuroprotection Against Ischemic Brain Damage. Stroke, 45(8), 2438-2443. View this article in WRRO
- Detection of Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack. Stroke, 45(2), 520-526.
- Neuroprotection in stroke: past, present, and future.. ISRN Neurology, 2014(2014). View this article in WRRO
- A methodical study of the role of trust at various development stages of virtual organisations. International Journal of Networking and Virtual Organisations, 14(4), 377-377.
- The impact of stent strut porosity on reducing flow in cerebral aneurysms.. J Neuroimaging, 23(4), 495-501.
- Role of histidine/histamine in carnosine-induced neuroprotection during ischemic brain damage.. Brain Res, 1527, 246-254.
- Sex differences of high-risk carotid atherosclerotic plaque with less than 50% stenosis in asymptomatic patients: an in vivo 3T MRI study.. AJNR Am J Neuroradiol, 34(5), 1049-S1.
- Safety and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke.. Stroke, 44(1), 205-212.
- Systematic review and meta-analysis of newly detected atrial fibrillation after ischaemic stroke/TIA using non-invasive and invasive cardiac monitoring. INTERNATIONAL JOURNAL OF STROKE, 7, 17-17.
- Stroke symptoms and risk factor awareness in high school children in Pakistan. International Journal of Stroke, 7(8).
- Anesthesia for endovascular treatment of acute ischemic stroke. Neurology, 79(13 SUPPL. 1).
- Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia.. Stroke, 43(6), 1632-1638.
- Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning.. J Neurosci, 32(21), 7278-7286.
- Abstract 3072: Prolonged Cardiac Monitoring for Detecting Paroxysmal AF or Flutter after Acute Ischemic Stroke: A Meta-Analysis. Stroke, 43(suppl_1).
- ABCD2 Score and Large-Artery Atherosclerosis. The Neurohospitalist, 2(1), 12-17.
- Symptomatic and asymptomatic carotid artery plaque.. Expert Rev Cardiovasc Ther, 9(10), 1315-1330.
- Neuroprotective effect of cyanidin-3-O-glucoside anthocyanin in mice with focal cerebral ischemia.. Neurosci Lett, 500(3), 157-161.
- Predictors of occult paroxysmal atrial fibrillation in cryptogenic strokes detected by long-term noninvasive cardiac monitoring.. Stroke Res Treat, 2011, 172074.
- Clinical significance of serum zinc levels in cerebral ischemia.. Stroke Res Treat, 2010, 245715.
- Endovascular treatment of symptomatic intracranial atherosclerotic disease.. Front Neurol, 1, 160.
- MR carotid plaque imaging and contrast-enhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms: an in vivo study at 3T.. AJNR Am J Neuroradiol, 31(8), 1395-1402.
- Sex differences in patients with asymptomatic carotid atherosclerotic plaque: in vivo 3.0-T magnetic resonance study.. Stroke, 41(8), 1630-1635.
- Peripheral neuropathy: differential diagnosis and management.. Am Fam Physician, 81(7), 887-892.
- Elevated levels of pre-procedural high-sensitivity C-reactive protein is associated with midterm restenosis after extra- and intracranial stenting.. J Neuroimaging, 20(1), 74-77.
- Response to letter by tsuda. Stroke, 40(12).
- Blood pressure changes after intravenous fosphenytoin and levetiracetam in patients with acute cerebral symptoms.. Epilepsy Res, 87(2-3), 268-271.
- The epidemiology of stroke in Pakistan: past, present, and future.. Int J Stroke, 4(5), 381-389.
- Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia.. J Neurosci Res, 87(11), 2541-2550.
- Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials. Stroke, 40(7), 2594-2600.
- Cardiac dysfunction after left permanent cerebral focal ischemia: the brain and heart connection.. Stroke, 40(7), 2560-2563.
- Distribution of carnosine-like peptides in the nervous system of developing and adult zebrafish (Danio rerio) and embryonic effects of chronic carnosine exposure.. Cell Tissue Res, 337(1), 45-61.
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations. Stroke, 40(6), 2244-2250.
- Hereditary neuropathy with liability to pressure palsies and amyotrophic lateral sclerosis.. Neurol Sci, 30(3), 241-245.
- Hypothermia Decreases The Fibrinolytic Activity Of Tissue Plasminogen Activator. STROKE, 40(4), E243-E243.
- Levetiracetam for managing neurologic and psychiatric disorders.. Am J Health Syst Pharm, 66(6), 541-561.
- Chemotherapy-related posterior reversible leukoencephalopathy syndrome.. Nat Clin Pract Neurol, 5(3), 163-169.
- The role of optical coherence tomography in vascular medicine. VASCULAR MEDICINE, 14(1), 63-71.
- Chronic total symptomatic carotid artery occlusion treated successfully with stenting and angioplasty.. J Neuroimaging, 19(1), 68-71.
- Extent of intra-arterial calcification on head CT is predictive of the degree of intracranial atherosclerosis on digital subtraction angiography.. Cerebrovasc Dis, 28(1), 45-48.
- Erratum: Treatment of a basilar artery occlusion with intra-arterial thrombolysis in a 3-year-old girl (Neurocrit Care) DOI: 10.1007/s12028-008-9086- 7). Neurocritical Care, 9(3), 412.
- Response to letter by Tsuda. Stroke, 39(11).
- Role of sildenafil in neurological disorders.. Clin Neuropharmacol, 31(6), 353-362.
- Lower pretreatment cerebral blood volume affects hemorrhagic risks after intra-arterial revascularization in acute stroke.. Neurosurgery, 63(5), 874-878.
- The WHO STEPwise Approach to Stroke Surveillance. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 18(10), 665-665.
- Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia.. J Neurosci Res, 86(13), 2984-2991.
- Intravascular ultrasound to assess extracranial vertebral artery restenosis: case report.. J Neuroimaging, 18(3), 336-339.
- Effect of pretreatment with statins on ischemic stroke outcomes.. Stroke, 39(6), 1779-1785.
- In-hospital stroke in a statewide stroke registry.. Cerebrovasc Dis, 25(1-2), 12-20.
- The effect of anticonvulsant drugs on the fibrinolytic activity of tissue plasminogen activator.. Cerebrovasc Dis, 25(1-2), 107-110.
- Treatment of a basilar artery occlusion with intra-arterial thrombolysis in a 3-year-old girl.. Neurocrit Care, 9(3), 357-360.
- Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome.. Neurol Neurochir Pol, 42(1), 55-59.
- Carnosine is neuroprotective against permanent focal cerebral ischemia in mice.. Stroke, 38(11), 3023-3031.
- Implementation of an emergency department-based transient ischemic attack clinical pathway: A pilot study in knowledge translation. ACADEMIC EMERGENCY MEDICINE, 14(11), 1114-1119.
- The mTOR pathway as a potential target for the development of therapies against neurological disease.. Drug News Perspect, 20(8), 495-499.
- Transcranial Doppler measurements in migraine and nitroglycerin headache.. J Headache Pain, 8(5), 289-293.
- US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results [4]. Stroke, 38(9).
- Role of intravenous levetiracetam in status migrainosus [5]. Journal of Headache and Pain, 8(2), 143-144. View this article in WRRO
- IV levetiracetam in the management of non-convulsive status epilepticus.. Neurocrit Care, 7(1), 36-39.
- Transcranial Doppler: an introduction for primary care physicians.. J Am Board Fam Med, 20(1), 65-71.
- Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?. VASCULAR MEDICINE, 12(3), 243-249.
- The therapeutic potential of statins in neurological disorders. CURRENT MEDICINAL CHEMISTRY, 14(1), 103-112.
- IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.. Neurology, 66(3), 306-312.
- Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke. STROKE, 36(12), 2705-2711.
- Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing inducible NO synthase and peroxynitrite in ischemic stroke.. Stroke, 36(12), 2705-2711.
- Carnosine is neuroprotective in a mouse model of stroke. Journal of Cerebral Blood Flow & Metabolism, 25(1_suppl), S313-S313.
- Minocycline has no effect on the fibrinolytic activity of alteplase. ANNALS OF PHARMACOTHERAPY, 39(2), 387-388.
- Ischemia and ischemic tolerance in the brain: an overview.. Neurotoxicology, 25(6), 895-904.
- The potential of minocycline for neuroprotection in human neurologic disease.. Clin Neuropharmacol, 27(6), 293-298.
- Images in vascular medicine. An unusual presentation of cerebral sinus thrombosis.. Vasc Med, 9(3), 225-226.
- Epstein–Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain, 125(1), 159-165.
- Differences in Vulnerability to Permanent Focal Cerebral Ischemia Among 3 Common Mouse Strains. Stroke, 31(11), 2707-2714.
- The order of draw of blood specimens into additive containing tubes not affect potassium and calcium measurements.. Journal of Clinical Pathology, 49(12), 1019-1020.
- Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes. Seizure, 5(3), 229-234.
- Involvement of alpha 1-adrenoceptors in the depolarizing but not the hyperpolarizing responses of motorneurones in the neonate rat to noradrenaline. Neuropharmacology, 1399-404.
- Cerebral perfusion alterations in healthy young adults due to two genetic risk factors of Alzheimer’s disease: APOE and MAPT. Journal of Cerebral Blood Flow & Metabolism.
- Association that Neuroimaging and Clinical Measures Have with Change in Arm Impairment in a Phase 3 Stroke Recovery Trial. Annals of Neurology.
- Optimizing non-invasive vagus nerve stimulation for treatment in stroke. Neural Regeneration Research.
- Dominant Parietal Lobe Ischaemic Stroke Presenting as Alien Hand Syndrome. Advances in Clinical Neuroscience & Rehabilitation.
- The Potential of Adaptive Design in Animal Studies. International Journal of Molecular Sciences, 16(10), 24048-24058. View this article in WRRO
- Fusion of Higher Order Spectra and Texture Extraction Methods for Automated Stroke Severity Classification with MRI Images. International Journal of Environmental Research and Public Health, 18(15), 8059-8059.
Chapters
- Electroceutical Approaches for the Treatment of Traumatic Brain Injury, Electroceuticals (pp. 55-73). Springer International Publishing
- CHAPTER 22. Carnosine-Induced Neuroprotection, Food and Nutritional Components in Focus (pp. 412-431). Royal Society of Chemistry
- Chapter 6. The Molecular Neuroprotective Strategies in Cerebral Ischemia: An Insight into Emerging Treatments for Oxidative Stress, Acute Brain Impairment (pp. 82-104). Royal Society of Chemistry
Conference proceedings papers
- Modulating The Role And Function Of Macrophages In Human Symptomatic Carotid Stenosis: Potential Mechanisms For Stabilisation Of Atherosclerotic Carotid Plaques. INTERNATIONAL JOURNAL OF STROKE, Vol. 19(3_SUPPL) (pp 39-39)
- Quality, not quantity, of walking correlates with deep grey matter in progressive Multiple Sclerosis. MULTIPLE SCLEROSIS JOURNAL, Vol. 29 (pp 317-318)
- 198 Should we thrombolyse cognitively impaired patients with acute ischaemic stroke?. Journal of Neurology, Neurosurgery & Psychiatry, Vol. 93(9) (pp e2.160-e2.160)
- BS1 Reprogramming human macrophages with drug X: potential mechanisms for stabilisation of atherosclerotic plaques. Basic science
- INTERVENTIONS TO PREVENT AND TREAT POST STROKE FATIGUE: A SYSTEMATIC REVIEW AND META-ANALYSIS. INTERNATIONAL JOURNAL OF STROKE, Vol. 15(1_SUPPL) (pp 660-660)
- EFFECT OF EXERCISE INTERVENTIONS ON HEALTH-RELATED QUALITY OF LIFE AFTER STROKE AND TRANSIENT ISCHAEMIC ATTACK: A SYSTEMATIC REVIEW AND META-ANALYSIS.. INTERNATIONAL JOURNAL OF STROKE, Vol. 15(1_SUPPL) (pp 657-657)
- A COMMUNITY-BASED EXERCISE REFERRAL PROGRAMME TO PROMOTE CARDIOVASCULAR HEALTH IN STROKE AND TIA PATIENTS: A PILOT FEASIBILITY STUDY. INTERNATIONAL JOURNAL OF STROKE, Vol. 15(1_SUPPL) (pp 142-142)
- UNDERSTANDING THE FACILITATORS AND BARRIERS TO EXERCISE AFTER STROKE AMONG PATIENTS, EXERCISE PROFESSIONALS AND CLINICIANS.. INTERNATIONAL JOURNAL OF STROKE, Vol. 15(1_SUPPL) (pp 260-260)
- PHYSIOLOGICAL RESPONSE AND PERCEIVED EXERTION DURING RECUMBENT AEROBIC CYCLING FOLLOWING ACUTE STROKE. INTERNATIONAL JOURNAL OF STROKE, Vol. 15(1_SUPPL) (pp 212-212)
- Stroke and TIA awareness and response to symptoms study (STARSS): assessing the relationship between stroke knowledge and help-seeking behaviour. INTERNATIONAL JOURNAL OF STROKE, Vol. 13 (pp 21-21)
- P16 HUMAN MACROPHAGE SUBSETS IN THE PATHOGENESIS OF CAROTID ATHEROSCLEROSIS. Cardiovascular Research, Vol. 114(suppl_2) (pp S5-S6)
- 116 Semi-quantitative imaging of macrophages in human carotid atherosclerotic plaques. Basic Science
- Microglial activation in recent ischemic stroke: comparison of two TSPO tracers. JOURNAL OF NUCLEAR MEDICINE, Vol. 58
- Difference in Acute Ischemic Post Thrombolytic Stroke Outcomes in Pre Comprehensive and Post Comprehensive Status: Single Center Experience. STROKE, Vol. 47
- Inter-rater Reliability of Transient Ischemic Attack Diagnosis in the Emergency Department. STROKE, Vol. 41(4) (pp E203-E203)
- Stroke Symptoms and Risk Factor Awareness Amongst High School Children in Pakistan. STROKE, Vol. 41(4) (pp E291-E291)
- Concordance Between Patient Bedside Dysphagia Assessment Results Obtained From Neurological Nurses and Speech Pathologists. STROKE, Vol. 41(4) (pp E230-E230)
- Predictors of discharge disposition for TIA cases presenting to community-based emergency departments. STROKE, Vol. 39(2) (pp 704-704)
- Ability of the ABCD2 clinical prediction rule to identify low-risk TIA cases in community-based emergency departments. STROKE, Vol. 39(2) (pp 558-558)
- BLOOD PRESSURE CHANGES AFTER INTRAVENOUS LOADING WITH FOSPHENYTOIN AND LEVETIRACETAM IN PATIENTS WITH ACUTE CEREBRAL INSULTS. EPILEPSIA, Vol. 49 (pp 430-431)
- Implementation of a transient ischemic attack clinical pathway: A pilot study in knowledge translation. ANNALS OF EMERGENCY MEDICINE, Vol. 50(3) (pp S102-S102)
- Effect of pre-existing statin use on in-hospital mortality and functional status at discharge in stroke patients: A propensity-based analysis. CIRCULATION, Vol. 115(21) (pp E581-E582)
- The effect of hypoxic preconditioning on the mTOR pathway. STROKE, Vol. 37(2) (pp 682-682)
- Inhibition of brain GTP cyclohydrolase I and tetrahydrobiopterin attenuates cerebral infarction via reducing iNOS and peroxynitrite in ischemic stroke. JOURNAL OF THE NEUROLOGICAL SCIENCES, Vol. 238 (pp S388-S389)
- Factors associated with IV tPA use in eligible acute stroke patients in Michigan. STROKE, Vol. 35(1) (pp 335-335)
Preprints
- Reprogramming Human Inflammatory Macrophages in Symptomatic Carotid Stenosis: Potential Mechanisms for Stabilisation of Atherosclerotic Carotid Plaques, Cold Spring Harbor Laboratory.
- Remote Ischaemic Conditioning for Neurological Disorders – A Systematic Review and Narrative Synthesis, Springer Science and Business Media LLC.
- Gene Expression Studies in Down Syndrome; What Do They Tell Us about Disease Phenotypes?, MDPI AG.
- Electroceuticals: Advances in Electrostimulation Therapies. Cham: Springer.
- Research group
-
Doctoral Students
Professor Majid welcomes enquiries from students interested in pursuing a doctorate in translational and clinical research. Several projects, preclinical (translational) and clinical are available. These include development of vaccines for neurological diseases, remote conditioning, development of exosome technologies for therapeutics and development of novel neurotherapeutics.
Post-Doctoral Scientists (short and long-term):
Several preclinical and clinical projects are available.
- Teaching activities
-
Professor Majid is the Phase 3a Neurology Lead for Sheffield Medical school.